Amyotrophic Lateral Sclerosis Clinical Trials

183 recruitingLast updated: June 17, 2026

There are 183 actively recruiting amyotrophic lateral sclerosis clinical trials across 35 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Jacksonville, Florida, United States, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Amyotrophic Lateral Sclerosis Trials at a Glance

183 actively recruiting trials for amyotrophic lateral sclerosis are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 66 trials, with the heaviest enrollment activity in Boston, Jacksonville, and New York. Lead sponsors running amyotrophic lateral sclerosis studies include Istituto Auxologico Italiano, Neuralink Corp, and Johns Hopkins University.

Browse amyotrophic lateral sclerosis trials by phase

Treatments under study

About Amyotrophic Lateral Sclerosis Clinical Trials

Looking for clinical trials for Amyotrophic Lateral Sclerosis? There are currently 125 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Amyotrophic Lateral Sclerosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Amyotrophic Lateral Sclerosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 183 trials

Recruiting
Phase 2

A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)

Chronic respiratory failureNon-invasive ventilationRespiratory Insufficiency+7 more
University of Pennsylvania48 enrolled3 locationsNCT07071935
Recruiting

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Amyotrophic Lateral SclerosisFrontotemporal DementiaProgressive Supranuclear Palsy
National Institute of Neurological Disorders and Stroke (NINDS)360 enrolled1 locationNCT03225144
Recruiting
Phase 2

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis
Corcept Therapeutics279 enrolled35 locationsNCT05407324
Recruiting

Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Amyotrophic Lateral Sclerosis
University Rehabilitation Institute, Republic of Slovenia60 enrolled1 locationNCT05336760
Recruiting

Clinical Procedures to Support Research in ALS

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy+1 more
University of Miami1,200 enrolled11 locationsNCT03489278
Recruiting
Phase 1

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Insmed Gene Therapy LLC23 enrolled5 locationsNCT07290062
Recruiting
Phase 2

Tofersen in Non-SOD1 ALS

ALS (Amyotrophic Lateral Sclerosis)
Washington University School of Medicine30 enrolled2 locationsNCT07294144
Recruiting
Phase 3

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Amyotrophic Lateral Sclerosis
Prilenia500 enrolled16 locationsNCT07322003
Recruiting
Phase 2

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Amyotrophic Lateral Sclerosis(ALS)
PhenoNet, Inc.105 enrolled20 locationsNCT07142291
Recruiting
Not Applicable

Functional Outcomes and Control Using Synchron BCI - Australia

Neurologic DisorderMotor Neuron DiseaseMotor Neuron Disease / Amyotrophic Lateral Sclerosis+4 more
Synchron, Inc.10 enrolled1 locationNCT07533903
Recruiting
Phase 2

A Study of Ranolazine in ALS

Amyotrophic Lateral Sclerosis
Swathy Chandrashekhar, MBBS72 enrolled6 locationsNCT06527222
Recruiting
Phase 1Phase 2

Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

Amyotrophic Lateral Sclerosis
Vector Y Therapeutics12 enrolled11 locationsNCT07287397
Recruiting

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

Amyotrophic Lateral Sclerosis
Loma Linda University160 enrolled1 locationNCT04097158
Recruiting
Phase 2Phase 3

HEALEY ALS Platform Trial - Master Protocol

Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD1,500 enrolled81 locationsNCT04297683
Recruiting
Not Applicable

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

AnarthriaAmyotrophic Lateral SclerosisSpinal Cord Injuries+5 more
Leigh R. Hochberg, MD, PhD.3 enrolled2 locationsNCT05724173
Recruiting
Not Applicable

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Amyotrophic Lateral SclerosisSpinal Cord Injurieslocked-in Syndrome+3 more
Leigh R. Hochberg, MD, PhD.27 enrolled6 locationsNCT00912041
Recruiting
Not Applicable

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

Amyotrophic Lateral Sclerosis(ALS)Motor Neuron Disease / Amyotrophic Lateral SclerosisPrimary Lateral Sclerosis (PLS)
Nova Southeastern University10 enrolled1 locationNCT07187388
Recruiting
Phase 1Phase 2

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

Amyotrophic Lateral Sclerosis(ALS)
Nura Bio80 enrolled6 locationsNCT07369076
Recruiting
Phase 2

Study of COYA 302 for the Treatment of ALS

Amyotrophic Lateral Sclerosis(ALS)
Coya Therapeutics120 enrolled25 locationsNCT07161999
Recruiting

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Amyotrophic Lateral Sclerosis
Sykehuset Telemark1,200 enrolled17 locationsNCT05119387